Publication | Closed Access

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

Autoimmune DiseaseHepatologyViral HepatitisMedicineImmunologyHepatitis BHepatitisHbsag SeroconversionAutoimmunityChronic Hepatitis BLiver DiseaseChronic Viral InfectionMolecular DiagnosticsCurrent Nucleos